Pharmacy as a profession drops: U.S. News rankings
February 19th 2014Pharmacy as a profession dropped a few notches to fifth place in the most recent U.S. News & World Report rankings for all jobs and placed third on the list of best healthcare jobs, behind nurse practitioner and dentist. It had placed third as the best profession overall last year.
Read More
Lawsuits mount over bleeding risks of dabigatran
February 17th 2014Boehringer Ingelheim is facing lawsuits in the United States over claims that dabigatran etexilate mesylate (Pradaxa) capsules, a blood-thinner used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem, causes severe and fatal bleeding.
Read More
30-day hospital readmission rates vary after inpatient rehab
February 17th 2014Nearly 12% of Medicare patients who receive inpatient rehabilitation following discharge from acute-care hospitalization are readmitted to the hospital within 30 days after discharge from the rehabilitation facility, according to a study in the Feb. 12 issue of the Journal of the American Medical Association.
Read More
Combination therapy with a lower-intensity statin and bile acid sequestrant or ezetimibe lowered LDL cholesterol similar to or better than higher-intensity statin monotherapy among patients with high risk for atherosclerotic cardiovascular disease (ASCVD), according to a study published February 11 online in the Annals of Internal Medicine.
Read More
Pharma, government, and nonprofit organizations unite in search for new therapies
February 11th 2014The National Institutes of Health (NIH), FDA, 10 biopharmaceutical companies, the Pharmaceutical Research and Manufacturers of America, and several nonprofit organizations have launched an unprecedented public/private partnership to “transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets of disease,” announced a recent statement from the NIH.
Read More
Naproxen CV safety evidence not conclusive enough to warrant label change, FDA says
February 11th 2014After examining the latest research on nonsteroidal anti-inflammatory drugs (NSAIDs)-specifically whether naproxen carries lower cardiovascular (CV) risks than ibuprofen-an FDA panel has voted down the CV safety claim for naproxen.
Read More
Engaging pharmacists in health IT key to medication adherence
February 6th 2014Engaging pharmacists in healthcare information technology is crucial to increasing overall medication adherence in healthcare, panelists on the “Connected Health, Better Adherence” roundtable at the Pew Conference Center in Washington, DC, told attendees last week.
Read More
Will other chain pharmacies follow CVS in banning the sale of cigarettes?
February 6th 2014An interdisciplinary group of pharmacists, pharmacy school and medical school faculty, pharmacy students, nurses, physicians, attorneys, and health advocates have called on Walgreens and Rite Aid to join CVS Caremark and stop the sale of tobacco products in their stores.
Read More
CVS Caremark will drop tobacco products in October
February 5th 2014CVS Caremark is recognizing that cigarettes and pharmacies don't mix and will stop selling cigarettes and other tobacco products at its more than 7,600 CVS/pharmacy stores across the United States by October 1, 2014. This move makes CVS/pharmacy the first national pharmacy chain to take this step in support of the health and well-being of its patients and customers.
Read More
Holes in the drug market place: How do we overcome these obstacles?
February 3rd 2014Complex diseases present complex challenges for researchers, clinicians, drug manufacturers, and FDA for a variety of reasons. The impact, however, is felt at the patient level, particularly when there are no FDA-approved treatments. In some cases, such as myalgic encephalomyelitis, commonly known as chronic fatigue syndrome (ME/CFS), the devastating effects of the disease are exacerbated by the huge deficit in the drug application and approval pipeline. This leaves the patient population with little hope.
Read More
The high cost of acute otitis media
February 3rd 2014Researchers recently determined that acute otitis media is associated with an incremental increase in outpatient health care costs of $314 per child per year in the United States, which translates into approximately $2.88 billion in added health care expense annually.
Read More
Drugs in Perspective: Oxytrol goes over-the-counter
February 3rd 2014Anti-muscarinic drugs are an option in the treatment of overactive bladder which is defined as urinary urgency with or without urge incontinence, usually accompanied by frequency and nocturia, in the absence of a urinary tract infection or other obvious pathology.Oral oxybutynin has been available by prescription for over 40 years, initially marketed as Ditropan® and Ditropan XL® although now generically availably, in addition to the transdermal patch Oxytrol and transdermal gel Gelnique. As an antagonist at muscarinic receptors, oxybutynin leads to relaxation of the smooth muscle of the bladder which leads to increased bladder capacity, decreased involuntary contractions and decreased urgency and frequency of both voluntary and incontinent episodes. The suggested dose is one patch applied for 4 consecutive days, after which the patch should be removed and a new one applied.
Read More
Adding evolocumab in combination with statins can help reduce high cholesterol
February 3rd 2014Adding evolocumab (Amgen) to statin therapy may help patients control their low-density lipoprotein cholesterol (LDL-C) levels when high doses of statins are not sufficient, according to results from a recent phase 3 study.
Read More